
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
Table of Contents
almost 23 years ago
PE's Annual Sales and Marketing Employment Survey: The Big Squeezealmost 23 years ago
Streamlining For Success with Fred Price of BioMarinalmost 23 years ago
The Making of a New Disease





